María Pascual‐Lucas

Author

María Pascual‐Lucas

Also Known As

M. Pascual-Lucas, Maria Pascual-Lucas, Maria Pascual‐Lucas, María Pascual Lucas, María Pascual-Lucas, María Pascual‐Lucas, V Pérez-Grijalba, V. Pérez-Grijalba

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Universidad de Navarra Universitat de Barcelona Grifols (Spain)

About

María Pascual‐Lucas is an author at Universidad de Navarra specializing in social sciences, neuroscience, and neurodegenerative diseases.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	335
2	Social Sciences	3	3	335
3	Neuroscience	3	3	335
4	Neurology	2	2	196
5	Cell Biology	1	1	139

María Pascual‐Lucas

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Pivotal Role of TLR4 Receptors in Alcohol-Induced Neuroinflammation and Brain Damage Silvia Alfonso‐Loeches, María Pascual‐Lucas, Ana María Andrés Blanco, Journal of Neuroscience	2010	571
Tadalafil crosses the blood–brain barrier and reverses cognitive dysfunction in a mouse model of AD Carolina García, Ana Ricobaraza, María Pascual‐Lucas, Neuropharmacology Neurodegenerative DiseasesAlzheimer's DiseaseBlood–brain BarrierNeurophysiologyMedicine	2012	184
Insulin‐like growth factor 2 reverses memory and synaptic deficits in <scp>APP</scp> transgenic mice María Pascual‐Lucas, Silvia Viana da Silva, Marianna Di Scala, EMBO Molecular Medicine Knockout MouseSynaptic PlasticityNeurodegenerative DiseasesSignal TransductionMolecular Neuroscience	2014	139
Safety, tolerability and immunogenicity of an active anti-Aβ40 vaccine (ABvac40) in patients with Alzheimer’s disease: a randomised, double-blind, placebo-controlled, phase I trial Ana-María Lacosta, María Pascual‐Lucas, Pedro Pesini, Alzheimer s Research & Therapy	2018	106
Phenotypic and functional analysis of SHANK3 stop mutations identified in individuals with ASD and/or ID Daniela M Cochoy, Alexander Kolevzon, Yuji Kajiwara, Molecular Autism	2015	95
Concomitant histone deacetylase and phosphodiesterase 5 inhibition synergistically prevents the disruption in synaptic plasticity and it reverses cognitive impairment in a mouse model of Alzheimer’s disease Mar Cuadrado‐Tejedor, Carolina García, J. Sanzhez-Arias, Clinical Epigenetics	2015	66
Clinical performance of an antibody-free assay for plasma Aβ42/Aβ40 to detect early alterations of Alzheimer’s disease in individuals with subjective cognitive decline María Pascual‐Lucas, José Antonio Allué, Leticia Sarasa, Alzheimer s Research & Therapy	2023	38
The global Alzheimer's Association round robin study on plasma amyloid β methods Josef Pannee, Leslie M. Shaw, Magdalena Korecka, Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring	2021	35
Outstanding Phenotypic Differences in the Profile of Amyloid-β between Tg2576 and APPswe/PS1dE9 Transgenic Mouse Models of Alzheimer’s Disease José Antonio Allué, Leticia Sarasa, María Izco, Journal of Alzheimer s Disease NeurogenomicsTransgenic Mouse ModelsBiological Mass SpectrometryNeurochemical BiomarkersAlzheimer ’	2016	12
Clinical utility of an antibody‐free LC‐MS method to detect brain amyloid deposition in cognitively unimpaired individuals from the screening visit of the A4 Study José Antonio Allué, María Pascual‐Lucas, Leticia Sarasa, Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring	2023	10

Page 1